Skip to main navigation

Overview
News & Events
- News Releases
- Events & Presentations
Governance
Financials
- SEC Filings
- IRS Form 8937
Stock
Resources

News Releases

Year

10 Sep '24

Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases

03 Sep '24

Carisma Therapeutics to Present at Upcoming Conferences

08 Aug '24

Carisma Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

06 Aug '24

Carisma Therapeutics Announces Expansion of Its Scientific Advisory Board

06 Aug '24

Carisma Therapeutics Announces Upcoming Presentation at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2024

01 Jul '24

Carisma Therapeutics Announces Changes to its Board of Directors

27 Jun '24

Carisma Therapeutics Announces Nomination of First In Vivo CAR-M Development Candidate for Hepatocellular Carcinoma Under Collaboration with Moderna

25 Jun '24

Carisma Therapeutics to Participate in the Stifel 2024 Cell Therapy Forum

25 Jun '24

Carisma Therapeutics Granted FDA Fast Track Designation for CT-0525 for the Treatment of HER2-overexpressing Solid Tumors

13 Jun '24

Carisma Therapeutics Announces Adjournment of Annual Meeting of Stockholders

Pagination

Current page 1
Page 2
Page 3
Next page
Last page

Displaying 1 - 10 of 23

Site - Investor Tools

Print Page
Email Alerts
RSS Feeds
IR Contact

Request Email Alerts

© 2024 Carisma Therapeutics Inc. All rights reserved.